GenMont Biotech Incorporation (TPE:3164)
16.95
+0.25 (1.50%)
Oct 8, 2026, 1:30 PM CST
| Market Cap | 1.46B -12.5% |
| Revenue (ttm) | 382.11M -1.1% |
| Net Income | 69.17M +344.7% |
| EPS | 0.80 +345.5% |
| Shares Out | 86.01M |
| PE Ratio | 21.16 |
| Forward PE | n/a |
| Dividend | 0.80 (4.72%) |
| Ex-Dividend Date | Apr 8, 2026 |
| Volume | 54,508 |
| Open | 16.70 |
| Previous Close | 16.70 |
| Day's Range | 16.60 - 16.95 |
| 52-Week Range | 15.35 - 19.75 |
| Beta | 0.06 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 11, 2026 |